Segment Reporting by business sector* Audited by KPMG

[ XLS ]

*

The previous year’s figures have been adjusted in accordance with the explanations "Changes in the reporting structure"

 

Merck Serono

Consumer
Health Care

Pharmaceuticals

Group/ Continuing Operations

€ million

2007

2006

2007

2006

2007

2006

2007

2006

Sales

4,187.0

1,902.4

418.2

398.3

4,605.2

2,300.7

6,775.1

4,440.1

Royalty income

270.7

12.0

1.5

1.5

272.2

13.5

282.0

19.5

Total revenues

4,457.7

1,914.4

419.7

399.8

4,877.4

2,314.2

7,057.1

4,459.6

Gross margin

3,764.7

1,420.6

283.7

263.9

4,048.4

1,684.5

5,277.3

2,892.3

Selling, general and administration

–1,980.9

–781.8

–210.0

–197.2

–2,190.9

–979.0

–2,717.1

–1,466.1

Research and development

–878.6

–471.5

–12.0

–10.4

–890.6

–481.9

–1,027.7

–615.4

Operating result

356.9

162.9

59.6

54.5

416.5

217.4

976.0

798.6

Exceptional items

–743.6

–21.9

–743.6

–21.9

–775.6

232.6

Earnings before interest and tax (EBIT)

–386.7

141.0

59.6

54.5

–327.1

195.5

200.4

1,031.2

Net operating assets

9,884.8

2,841.5

281.0

276.0

10,165.8

3,117.5

12,179.9

5,122.1

Segment liabilities

–799.0

–272.3

–54.5

–55.0

–853.5

–327.3

–1,128.0

–607.4

Capital spending on property, plant and equipment

147.6

69.9

6.1

4.5

153.7

74.4

263.3

219.5

Investments in intangible assets

91.7

38.5

0.8

1.0

92.5

39.5

101.6

43.1

Net cash flows from operating activities

875.9

147.5

50.9

59.3

926.8

206.8

1,181.4

612.8

Net cash flows from investing activities

–7,381.0

–1,672.4

–4.0

–0.6

–7,385.0

–1,673.0

–7,525.4

–1,385.2

Free cash flow

–6,505.1

–1,524.9

46.9

58.7

–6,458.2

–1,466.2

–6,307.9

–1,195.8

Impairment losses

–100.2

–12.9

–0.3

–100.2

–13.2

–109.3

–47.5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liquid Crystals

Performance &
Life Science Chemicals

Chemicals

Group/ Continuing Operations

€ million

2007

2006

2007

2006

2007

2006

2007

2006

Sales

909.4

892.4

1,231.3

1,213.3

2,140.7

2,105.7

6,775.1

4,440.1

Royalty income

6.3

2.6

3.5

3.4

9.8

6.0

282.0

19.5

Total revenues

915.7

895.0

1,234.8

1,216.7

2,150.5

2,111.7

7,057.1

4,459.6

Gross margin

611.3

592.0

615.1

612.9

1,226.4

1,204.9

5,277.3

2,892.3

Selling, general and administration

–42.5

–35.8

–409.9

–388.9

–452.4

–424.7

–2,717.1

–1,466.1

Research and development

–78.8

–66.7

–58.3

–66.7

–137.1

–133.4

–1,027.7

–615.4

Operating result

486.6

486.1

144.4

155.4

631.0

641.5

976.0

798.6

Exceptional items

–34.5

–34.5

–775.6

232.6

Earnings before interest and tax (EBIT)

486.6

486.1

144.4

120.9

631.0

607.0

200.4

1,031.2

Net operating assets

915.1

897.2

1,053.0

1,073.4

1,968.1

1,970.6

12,179.9

5,122.1

Segment liabilities

–90.0

–96.2

–176.9

–178.0

–266.9

–274.2

–1,128.0

–607.4

Capital spending on property, plant and equipment

48.6

72.8

57.9

68.8

106.5

141.6

263.3

219.5

Investments in intangible assets

1.5

0.6

7.5

2.9

9.0

3.5

101.6

43.1

Net cash flows from operating activities

474.0

421.1

181.1

221.4

655.1

642.5

1,181.4

612.8

Net cash flows from investing activities

–49.2

–49.2

–49.3

–88.9

–98.5

–138.1

–7,525.4

–1,385.2

Free cash flow

424.8

371.9

131.8

132.5

556.6

504.4

–6,307.9

–1,195.8

Impairment losses

–0.2

–0.3

–8.9

–33.7

–9.1

–34.0

–109.3

–47.5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate
and Other

Discontinued Operations (Generics)

Reversal Discontinued Operations (Generics)

Group/ Continuing Operations

€ million

2007

2006

2007

2006

2007

2006

2007

2006

Sales

29.2

33.7

1,391.8

1,818.5

–1,391.8

–1,818.5

6,775.1

4,440.1

Royalty income

2.7

5.5

–2.7

–5.5

282.0

19.5

Total revenues

29.2

33.7

1,394.5

1,824.0

–1,394.5

–1,824.0

7,057.1

4,459.6

Gross margin

2.5

2.9

656.8

899.1

–656.8

–899.1

5,277.3

2,892.3

Selling, general and administration

–73.8

–62.4

–364.6

–449.5

364.6

449.5

–2,717.1

–1,466.1

Research and development

–0.1

–95.3

–132.1

95.3

132.1

–1,027.7

–615.4

Operating result

–71.5

–60.3

188.7

306.8

–188.7

–306.8

976.0

798.6

Exceptional items

–32.0

289.0

3,561.5

–13.2

–3,561.5

13.2

–775.6

232.6

Earnings before interest and tax (EBIT)

–103.5

228.7

3,750.2

293.6

–3,750.2

–293.6

200.4

1,031.2

Net operating assets

46.0

34.0

19.4

1,042.3

–19.4

–1,042.3

12,179.9

5,122.1

Segment liabilities

–7.6

–5.9

–7.5

–332.1

7.5

332.1

–1,128.0

–607.4

Capital spending on property, plant and equipment

3.1

3.5

19.5

33.7

–19.5

–33.7

263.3

219.5

Investments in intangible assets

0.1

0.1

19.5

13.5

–19.5

–13.5

101.6

43.1

Net cash flows from operating activities

–400.5

–236.5

36.9

198.9

–36.9

–198.9

1,181.4

612.8

Net cash flows from investing activities

–41.9

425.9

4,797.9

–76.5

–4,797.9

76.5

–7,525.4

–1,385.2

Free cash flow

–406.3

–234.0

4,834.8

122.4

–4,834.8

–122.4

–6,307.9

–1,195.8

Impairment losses

–0.3

–109.3

–47.5